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Sunday, February 21, 2010 123aparalleled by impaired Kþ coordination in the selectivity filter (Choi et al.,
1991; Hoshi et al., 1990; Lopez-Barneo et al., 1993). The mechanism of
KCNQ1 inactivation and its modulation by external Kþ are dissimilar to the
mechanism described for C-type inactivation in Shaker-like Kþ channels (Gi-
bor et al., 2007). Further, inactivation of wild-type (WT) KCNQ1 channels be-
comes evident only in the characteristic hooked tail currents which reflect re-
covery from inactivation (Abitbol et al., 1999; Pusch et al., 1998; Tristani-
Firouzi and Sanguinetti, 1998). We use a combination of functional-structural
analysis combined with mathematical and 3D-structural modeling to gain in-
sights into the structural rearrangements during KCNQ1-inactivation. We
show that the Kv7.1 a-subunits act in a concerted way to initiate KCNQ1-in-
activation.
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The response of voltage-dependent Kþ (Kv) channels to a change in membrane
voltage involves a molecular device, which couples voltage-driven conforma-
tional changes to gate opening and closing within the channel’s conduction
pathway. To further our understanding of the coupling choreography we
have studied how changes in coupling strength instigate the Kv channel to
open before and after voltage-sensor activation. We used single and double mu-
tations in a Kv channel pore domain to analyze coupling sensitive sites. We ob-
served in the mutational effects a correlation between coupling strength and
non-obligatory Kv channel gating that is well described with a four-state allo-
steric gating model. Mapping the data onto known Kv channel structures
showed that coupling-sensitive amino acid residues are strategically clustered
to a small area between pore gate and the interface of pore and voltage sensors.
We propose that the physical contact at the interface between voltage sensor
and pore domain is an important determinant of altered coupling strengths lead-
ing to obligatory and non-obligatory Kv channel gating.
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Diclofenac Activates Kv7.4 and Inhibits Kv7.5 Potassium Channels Heter-
ologously Expressed in A7r5 Vascular Smooth Muscle Cells
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Members of the KCNQ (Kv7) voltage-gated potassium channel gene family are
differentially expressed through the body. Five Kv7 subtypes play major roles
in regulation of membrane potential and cell excitability within different tis-
sues. Well known functions of Kv7.1 in cardiac action potential duration,
Kv7.2/7.3 in neuronal excitability, Kv7.4 in hearing and an emerging role of
Kv7.5 in vascular tone, increases the demand for channel modulating drugs
that exhibit selectivity among Kv7 subtypes. Diclofenac, an anti-inflammatory
drug, was found to be a novel Kv7.2/7.3 channel opener and was used as a tem-
plate to synthesize new activators and inhibitors of neuronal KCNQ channels
(Kv7.2/7.3 and Kv7.4). We compare affects of diclofenac on human Kv7.4
and Kv7.5 currents using A7r5 rat aortic smooth muscle cells as an expression
system and perforated patch-clamp techniques. Diclofenac, at 100˛1/4M, in-
creased maximal conductance of Kv7.4 channels by 1.5-fold and induced a neg-
ative shift in the activation curve (by 9mV). Surprisingly, the same concentra-
tion of diclofenac (100˛1/4M) reduced maximal conductance of Kv7.5
channels by 2-fold, but also induced a robust negative shift in the activation
curve (by 30mV). For the both Kv7.4 and Kv7.5, application of diclofenac
(100˛1/4M) reduced the deactivation rate of the current. For Kv7.4, the deac-
tivation rate was 1.7-fold slower in the presence of diclofenac, independent of
the voltage in the range from 120mV to 90mV. In contrast, for Kv7.5 the
reduced deactivation rate in the presence of diclofenac was voltage-dependent,
changing linearly from 2-fold at 120mV to 4-fold at 90mV. These differ-
ences in diclofenac action on two members of the Kv7 channel family may re-
flect structural differences between Kv7.4 and Kv7.5 and make diclofenac
a useful tool to distinguish between Kv7.4 and Kv7.5 currents in native tissues.Ca-Activated Channels
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of Nevada, Reno, Reno, NV, USA.Calcium-activated chloride channels (CACCs) share common pharmacological
properties with SLO (KCNMA1)-encoded large conductance Kþ channels
(KCa1.1) and it has been suggested they may co-exist in a macromolecular com-
plex (Greenwood, I. A., and Leblanc, N. Trends Pharmacol Sci28: 1-5, 2007;
Saleh et al. J Pharmacol Exp Ther 321: 1075-1084, 2007; Sones et al. Br J
Pharmacol 158: 521-531, 2009). As KCa1.1 channels are known to localise
to cholesterol and caveolin-rich lipid rafts (caveolae) the present study investi-
gated whether Ca2þ-sensitive Cl- currents in vascular myocytes were affected
by the cholesterol depleting agent Beta-methyl cyclodextrin (Beta-MCD).
Calcium-activated chloride and potassium currents were recorded from single
murine portal vein myocytes in whole cell voltage clamp. Western blot was
undertaken following sucrose gradient ultracentrifugation using protein ly-
sates from whole portal veins. Ca2þ-activated Cl- currents were augmented
by Beta-MCD with a rapid time-course (t0.5 ¼ 1.8 min). Beta-MCD had no
effect on the bi-modal response to niflumic acid or anthracene-9-carboxylate
but completely removed the inhibitory effects of the KCa1.1 blocker paxilline
and the stimulatory effect of the KCa1.1 activator NS1619. Discontinuous
sucrose density gradients followed by Western blot analysis revealed that
KCa1.1 was present in lipid fractions, co-localising with lipid raft markers
caveolin and flotillin-2. The newly identified candidate for calcium-activated
chloride channels TMEM16A, co-localised to the same fractions as KCa1.1.
These data reveal that CACC properties are influenced by lipid raft integrity.
The results also provide a structural basis explaining the intimate functional
interaction that exist between KCa1.1 and CACCs in generating STOCs and
STICs and how they regulate resting membrane potential and tone in vascular
myocytes.643-Pos
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Pulmonary arterial hypertension (PAH) in humans is defined by a pulmonary
artery pressure (PAP) exceeding 25 mm Hg at rest, and 30 mm Hg during
physical activity. Three major factors contribute to elevating PAP in PAH pa-
tients: 1) enhanced vasoconstriction; 2) reduction of lumen diameter due to
remodeling of the arterial wall; and 3) enhanced clot formation. It has been
recently suggested that Cl- currents can regulate proliferation of cultured rat
pulmonary artery (PA) smooth muscle cells (Liang et al., Hypertension 54:
286-293, 2009). The purpose of the present study was to determine if
Ca2þ-activated Cl- currents (ICl(Ca)) are altered in PA smooth muscle cells
from monocrotaline(MCT)-treated rats. Aged-matched male rats were either
injected with saline or a single dose of MCT (50 mg/kg) to induce PAH,
and the animals from both groups were sacrificed after 3 weeks. Rats treated
with MCT displayed an increase in right ventricular weight with no change in
left ventricular and septum weights, consistent with PAH. Patch clamp exper-
iments revealed that the cell capacitance, an index of cell surface, of PA cells
from MCT-injected rats was 40% greater than that of cells from saline-in-
jected rats. Time- and voltage-dependent ICl(Ca) elicited by 500 nM internal
free Ca2þ (buffered with 10 mM BAPTA) displayed outward rectification
in both groups but was more than ~ 2-fold larger in the MCT vs. saline group.
In both groups, the current ran down over time but significantly more on a per-
centage basis in MCT than control cells. In conclusion, the properties and reg-
ulation of ICl(Ca) appear to be altered in a validated animal model of PAH and
these results suggest that this anion current may represent a new therapeutic
target.
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Ca2þ-dependent Cl- currents (IClCa) are inhibited by phosphorylation in arterial
smooth muscle cells. We recently reported that niflumic acid (NFA), an inhib-
itor of IClCa, is less efficacious at blocking these currents in conditions promot-
ing phosphorylation (Wiwchar et al., Br J Pharmacol, in press, 2009). This
124a Sunday, February 21, 2010study aimed to assess whether another Cl- channel blocker, anthracene-9-car-
boxylic acid (A9C), is also affected by channel phosphorylation. A9C blocks
IClCa at positive potentials but paradoxically stimulates the inward IClCa tail af-
ter repolarization to negative potentials (Piper & Greenwood, Br J Pharmacol
138: 31-38, 2003). IClCa was evoked by pipette solutions containing 500 nM
free Ca2þ with or without 5 mM ATP to alter the state of phosphorylation.
Although A9C (1-500 uM) dose-dependently blocked steady state IClCa at
potentials positive to 0 mV in all cell groups, its maximal effect and sensitivity
to voltage were enhanced in cells dialyzed with 0 vs. 5 mM ATP. For example,
maximal block by 100 uM A9C was 35 and 73%, and V0.5 was 110 and 67 mV,
in cells with 5 vs 0 ATP, respectively. A9C enhanced IClCa tail at 80 mV by
causing a negative shift in voltage-dependence in both cell groups, with a larger
shift occurring in cells dialyzed with 5 mM ATP. Interestingly, 100 but not
500 uM A9C stimulated steady-state ICl(Ca) at potentials < 0 mV in cells dia-
lyzed with 0 ATP, a potential range where ICl(Ca) was unaffected in myocytes
dialyzed with 5 mM ATP. As with NFA, the complex actions of A9C on IClCa
are influenced by the state of channel phosphorylation and we propose the ex-
istence of at least two binding sites with different affinities for A9C.
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F233A Mutation in AT1R Interrupted Caveolae Targeting and Abolished
Regulation of hSlo Channel by Angiotensin II
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The large conductance Ca2þ-activated Kþ (BK) channels play an important role
in the regulation of vascular tone in response to changes in intracellular meta-
bolic status and Ca2þ homeostasis. Angiotensin II (Ang II)-mediated c-Src acti-
vation is known to inhibit the activities of BK channels. Recently, trafficking of
theAng II type I receptor (AT1R) into caveolaewas shown to be essential forAng
II signaling and activation of c-Src. We found that BK channels and the AT1R
signaling complex are colocalized in the caveolae of vascular smooth muscle
cells (VSMC). In this study, we examined the role of caveolae in the Ang
II-mediated modulation of BK channels by co-expressing hSlo channels,
AT1R, caveolin-1, and c-Src in HEK293 cells. Immunoblot analysis confirmed
that hSlo and AT1R were co-precipitated by anti-caveolin-1 antibody only in
cells co-transfected with caveolin-1, but not in those without caveolin-1, sug-
gesting that hSlo, AT1R, and caveolin-1 were physically associated. Exposure
to Ang II (2 mM) inhibited the hSlo current density by 32.752.8 %, and the
Ang II effect was blocked by Losartan (2 mM) with only 1.257.8 % current
inhibition. However, in cells coexpressing hSlo, c-Src, caveolin-1, and the
AT1R F233A mutant, which abolished its interaction with the caveolin-1 scaf-
folding domain, exposure to Ang II produced only 6.053.7% hSlo current inhi-
bition suggesting that caveolae targeting of AT1R is crucial for Ang II-mediated
BK channel regulation. These results were confirmed by experiments using
mouse VSMC. Ang II produced 40% inhibition of BK currents in cells from
wt mouse but had no effect on those from cav-1(-/-) animals. Hence, transloca-
tion of AT1R into caveolae upon agonist activation represents a critical step in
Ang II regulation of BK channels and vascular function.
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Cardiovascular sensitivity to anesthetics has been linked to the renin-angioten-
sin system (RAS), and it is thought to be related to the differences in cardio-
vascular collapse observed between SS and BN rats. In a previous study we
found that congenics carrying the BN renin allele (reninþ) in the SS back-
ground had the same cardiovascular sensitivity and low BK channel activity as
BN rats. On the other hand, congenics carrying the SS renin allele (renin-) dis-
played high BK activity and behaved like SS rats, suggesting that RSA could
be involved in differential responses. To test this hypothesis, the inhibition of
BK channel by angiotensin II (AngII, 100 nM) was evaluated in four strains.
Activity of BK was monitored from isolated mesenteric arterial smooth mus-
cle cells of SS and BN rats, and reninþ and renin- congenic rats in the cell-
attached mode at þ80 mV Em and in symmetrical 150 mM Kþ. Blockade by
paxilline (1 mM) confirmed identity of BK channel. Similar to findings from
our previous study, in the cell-attached mode the probability of BK channel
opening (Po) was different between SS (high Po) and BN (lower Po). The
BK activity of renin2- resembled that of SS, whereas BK activity of reninþ
matched BN. AngII had a greater inhibitory effect on channel Po in BN
(55þ7%) and reninþ (94þ2%) strains than in SS (9þ6%) and renin-(7þ2%) strains. Impaired renin expression and impaired RAS are associated
with lower sensitivity of BK to inhibition by AngII in SS than in BN rats. The
fact that reninþ and renin- strains follow a similar pattern appears to support
this conclusion.
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MaxiK channel, composed of the pore-forming a (MaxiKa) and regulatory b1
subunits, controls vascular tone via the activation or inhibition of its pore con-
ducting activity. Thromboxane A2 receptor (TPR), a G-protein coupled recep-
tor, induces potent vasoconstriction mediated by its agonist, thromboxane A2.
Previously, we demonstrated that U46619, the stable analogue of thromboxane
A2 inhibits MaxiK channel in vascular smooth muscle cell contributing to
U46619-induced vasoconstriction. In this study, we report that this inhibition
is reversed by nanomolar dehydrosoyasaponin I (DHS-I), a pharmacological
tool that indicates MaxiKa and b1 association and functional coupling. The re-
versing effect of DHS-I indicated that the MaxiK channels inhibited by U46619
could be coupled with regulatory b1 subunits. Co-immunoprecipitation and
double immunolabeling in co-expressing cells showed that TPR form a complex
with b1 on the plasma membrane. To identify the interacting sites in b1 respon-
sible for TPR-b1 complex formation, we prepared serial carboxyl-terminal
deletions of b1 and analyzed their interaction properties with TPR in co-
immunoprecipitation experiments. b1 lacking amino acids 103-191 reduces
the TPR-b1 association by 44 5 14% (p<0.01), while deletion of residues
73-191 completely reduces the TPR-b1 interaction, suggesting that amino acids
73 to 191 predominantly contribute to the TPR-b1 interaction. To further inves-
tigate how b1 regulates TPR-MaxiKa functional coupling, inside-out patch
clamp experiments were performed in HEK293T cells expressing TPRþMax-
iKa þ/- b1 subunit. We found that the b1 subunit reduces U46619-induced
MaxiKa inhibition in a dose-dependent manner. In summary, b1 interacts
with TPR forming a tripartite complex with MaxiKa and opposes to TPR ag-
onist-induced MaxiK channel inhibition serving as a buffer to vasoconstriction.
Thus, in pathological situations like hypertension or aging where b1 expression
is compromised the TPR-MaxiK complex would induce severe vasoconstric-
tion. Supported by NIH and AHA.
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The calcium-activated potassium channel KCa3.1 is critically involved in the
proliferation and migration of T cells, macrophages, dedifferentiated vascular
smooth muscle cells and fibroblasts by regulating membrane potential and cal-
cium influx. KCa3.1 has therefore been suggested as a potential therapeutic tar-
get for various diseases where activation and excessive proliferation of one or
more of these cell types is involved in the pathology. Using the selective small
molecule KCa3.1 blocker TRAM-34 as a pharmacological tool compound we
previously demonstrated that KCa3.1 blockade prevents restenosis in both
rats and pigs and reduces atherosclerosis development in ApoE-/- mice. We
now used two models of chronic allograft rejection and one model of kidney
fibrosis to evaluate whether KCa3.1 blockers might also be useful for the
prevention of transplant rejection and fibrotic kidney changes. In a murine
model of obliterative airway disease, where tracheas from CBA mice were
heterotopically transplanted into the greater omentum of C57Bl6 mice, both
genetic deficiency or pharmacological blockade of KCa3.1 with TRAM-34
reduced luminal obliteration from 9257% to 60529% or 61528% (n ¼ 6
per group). We further performed orthotopic aortic transplantations in the
PVG-to-ACI rat model and evaluated chronic allograft vasculopathy after
120 days. TRAM-34 at 10 mg/kg (35%) and 40 mg/kg (60%) dose-
dependently reduced chronic aortic luminal obliteration. Genetic disruption
of KCa3.1 and pharmacological blockade also reduced fibrotic marker expres-
sion, chronic tubulointerstitial damage, collagen deposition and alphaSMA(þ)
cells in kidneys following unilateral ureteral obstruction in mice. Taken to-
gether, our findings suggest that KCa3.1 channels are involved in the pathology
of obliterative airway disease, chronic allograft vasculopathy and fibrotic
kidney disease.
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